🔵 RECOVERY (Score 0.64) — Monday opens on strong footing after last week's triple catalyst (Trump-Xi trade deal, CSCO 12+ analyst raises, Cerebras IPO +68%). This week's selection rotates into semiconductor capex (AMAT 16+ raises), data center infrastructure (VRT), and rising-rate beneficiaries (SCHW, BBVA). 80% new tickers vs Friday's scan. Suite aux rétrospectives (note C+, 20% HR récent), nous avons ajusté : réduction poids Breakout quand régime <70% confiance, volume confirmation renforcée. ⚠ PANW earnings Tuesday after-hours — half position recommended pre-report.
Regime score at 0.64, classified as RECOVERY. Component scores: Credit 1.0 (HYG spread normalized), SPX 1.0 (above key DMAs at ~5,950), DXY 0.87 (dollar firm, slight headwind for multinationals), Liquidity 0.50 (neutral), TLT 0.50 (bonds under pressure — 30Y >5.1%), VIX 0.00 (elevated at ~22 — caution flag). Ensemble probability: neutral 42%, risk_on 38%, early_risk_off 15%, crisis 5%. No crisis gate triggered — full position sizing. Rétrospective feedback: Breakout HR 0% last week on regime shift — requiring volume confirmation >1.5× 20-day avg before Breakout entries this week.
Session strategy: Four converging themes for Monday: (1) Semiconductor capex cycle — AMAT 16+ analyst raises + VRT data center power infrastructure, both validated by Cerebras IPO +68% confirming AI compute demand; (2) CSCO momentum continuation + PANW cybersecurity — CSCO pulling back into consolidation zone after 194M-volume gap, PANW at 52W highs (earnings Tuesday — half position); (3) Rising-rate financials — 30Y yield >5.1% highest in a year benefits SCHW (NIM expansion) and BBVA (EU rate hold); (4) Geographic diversification — NVO EU healthcare pullback, JD China trade deal momentum, XLK/IBB broad ETF exposure for portfolio balance.
Monday, May 18, 2026
Market Regime: RECOVERY (Score 0.64)
Regime score at 0.64, classified as RECOVERY. Component scores: Credit 1.0 (HYG spread normalized), SPX 1.0 (above key DMAs at ~5,950), DXY 0.87 (dollar firm, slight headwind for multinationals), Liquidity 0.50 (neutral), TLT 0.50 (bonds under pressure — 30Y >5.1%), VIX 0.00 (elevated at ~22 — caution flag). Ensemble probability: neutral 42%, risk_on 38%, early_risk_off 15%, crisis 5%. No crisis gate triggered — full position sizing. Rétrospective feedback: Breakout HR 0% last week on regime shift — requiring volume confirmation >1.5× 20-day avg before Breakout entries this week.
Market Snapshot (Monday, May 18, 2026)
Index / Asset
Price
Change
Signal
S&P 500
~5,950
+0.5% Fri
Recovery intact ✅
NASDAQ
~21,200
+0.8% Fri
AI momentum strong ✅
Dow Jones
~42,500
+1.1% Fri
Industrials leading ✅
Russell 2000
~2,080
+0.4% Fri
Small-caps recovering ✅
VIX
~22
Elevated
Caution zone ⚠
30Y Treasury
>5.10%
Highest in 1yr
Rate pressure ⚠
10Y Treasury
4.46%
Stable
Below 4.50% ✅
Dollar (DXY)
~101
Firm
Slight headwind ⚠
Gold
~$3,200
+0.2%
Safe-haven stable ✅
Position Sizing: The Inverse-ATR Method
Week 4 — Advanced: Most traders obsess over entry timing but ignore position sizing — the single biggest determinant of long-term survival. The inverse-ATR method sizes each position inversely proportional to its Average True Range (volatility). High-volatility stocks (large ATR) get smaller positions; low-volatility names get larger ones. Formula: Position Size = (Account × Risk%) / (ATR × Multiplier). This means a volatile biotech at ATR $5 gets a smaller allocation than a stable utility at ATR $1. Result: each position contributes roughly equal dollar risk to the portfolio, preventing one volatile name from dominating P&L. All 6 DailyTickers modes use inverse-ATR sizing — it’s why Fortress (low risk) and Turbo (high risk) can coexist with different target risk percentages (0.5% vs 1.0%).
Three macro narratives shape Monday’s selection: (1) Semiconductor capex acceleration — AMAT received 16+ analyst target raises, the broadest consensus upgrade in the semi equipment space in 2026. Cerebras IPO surging +68% confirms that AI compute silicon demand is insatiable and expanding from GPUs into custom ASICs, advanced packaging, and power infrastructure (VRT). The capex cycle is self-reinforcing: more AI workloads → more chips → more equipment orders. (2) Rising-rate financials — 30Y Treasury yield breaching 5.1% (highest in a year) with inflation projected at 6% Q2 and traders pricing the next Fed move as a HIKE, not a cut. This environment massively benefits net interest margin plays: SCHW (5 analyst raises) and BBVA (EU rate hold + Sabadell M&A premium). The rotation from growth to value/financials has room to run. (3) Post-summit geographic rotation — Trump-Xi trade deal momentum carries into week 2 via JD.com (direct China e-commerce beneficiary at 8× forward PE), while NVO pullback and IBB momentum provide defensive healthcare ballast. The 80% new ticker rotation vs Friday responds to retro feedback: last week’s Breakout-heavy scan (0% HR) is rebalanced toward Momentum (35%) with stricter volume confirmation.
#1 AMAT — Applied Materials
AMAT
AMAT — Applied Materials
Semiconductor Equipment • NASDAQ • ~$160B mcap
$433.80
+0.00%
US 🇺🇸BreakoutScore 9516+ Analyst RaisesAI Capex Cycle☪ Halal
Applied Materials received 16+ analyst target raises this week — the broadest consensus upgrade in semiconductor equipment in 2026. AI capex cycle driving record orders for advanced packaging, EUV lithography, and high-bandwidth memory etching. Cerebras IPO surging +68% on day one confirms insatiable demand for AI compute silicon, directly benefiting AMAT as the dominant equipment supplier. BUY signal active with clean breakout above $420 prior resistance on heavy volume.
✅ Confirmations
16+ analyst target raises in one week — broadest semi equipment consensus upgrade of 2026
Cerebras IPO +68% confirms AI compute silicon demand is accelerating, not peaking
AI capex cycle self-reinforcing: more workloads → more chips → more AMAT equipment orders
Advanced packaging (CoWoS, HBM) revenue growing 40%+ YoY — AMAT is the dominant supplier
Volume confirmation >1.5× 20-day average on the breakout move (retro-adjusted threshold)
❌ Invalidations
Break below $393 (stop) = failed breakout — $400 psychological support must hold
China export restrictions tightening could crimp ~25% of AMAT revenue (DUV equipment to China)
Networking / AI Infrastructure • NASDAQ • ~$230B mcap
$117.99
+0.00%
US 🇺🇸MomentumScore 9312+ Analyst RaisesPost-Earnings Momentum☪ Halal
Cisco post-earnings momentum entering week 2 after the most bullish analyst response of 2026 — 12+ firms raised targets simultaneously. Gap from $93.22 to $122.79 on 194M volume (8x normal) validated AI infrastructure pivot. Enterprise networking demand inflecting on data center buildout. Entering pullback consolidation zone $110–$119 — ideal re-entry after the initial euphoria cools. Webex AI + Splunk integration creating recurring SaaS revenue streams.
✅ Confirmations
12+ analyst target raises in a single day — broadest post-earnings consensus upgrade of 2026
Gap-open from $93 to $123 on 194M volume (8x normal) — institutional accumulation confirmed
AI infrastructure pivot validated: enterprise networking demand inflecting on data center buildout
Break below $105 (stop) = gap fill risk; $107 gap support must hold
Post-earnings gap fills are common within 10 days — aggressive trailing required
Enterprise IT spend slowdown if recession fears accelerate could stall the order pipeline
Competition from Arista (ANET) on data center switching; CSCO premium may not hold
Entry: $110–$119
Stop Loss: $105.00
TP1: $133.00
TP2: $147.00
R/R: 1:2.1
Horizon: 10 days
#3 VRT — Vertiv Holdings
VRT
VRT — Vertiv Holdings
Data Center Power & Cooling • NYSE • ~$50B mcap
$370.75
+0.00%
US 🇺🇸MomentumScore 93AI Infrastructure3 Analyst Raises☪ Halal
Vertiv is the picks-and-shovels play for AI data center buildout — power distribution, thermal management, and liquid cooling for GPU clusters. Three analyst raises this week (BofA, Barclays, Jefferies) reflect accelerating order book visibility. CSCO earnings blowout validates enterprise data center demand as a read-through for VRT. Each new 100MW AI data center requires $200M+ in power/cooling infrastructure. Momentum entry $355–$374 with stop below $330 consolidation floor.
✅ Confirmations
3 analyst raises this week (BofA, Barclays, Jefferies) — accelerating order book visibility
CSCO earnings blowout validates enterprise data center demand as direct read-through for VRT
AI power demand secular: each 100MW data center = $200M+ in VRT-addressable power/cooling
Liquid cooling adoption inflection — VRT is #1 in thermal management for GPU clusters
❌ Invalidations
Break below $336 (stop) = trend reversal; prior consolidation floor must hold
Data center buildout pause if hyperscaler CapEx guidance disappoints in Q2 earnings
Margin pressure from supply chain bottlenecks on electrical components (transformers, switchgear)
Valuation stretch at ~35x forward — vulnerable to multiple compression if growth slows
US 🇺🇸BreakoutScore 92Rising Rates Play5 Analyst RaisesCONV
Charles Schwab breakout above $88 resistance on 5 analyst raises and the most favorable rate environment in a year. 30Y Treasury yield breaching 5.1% — highest since May 2025 — directly expands net interest margin, SCHW’s core earnings driver. With inflation projected at 6% Q2 and traders pricing the next Fed move as a HIKE, the NIM tailwind has room to run. Financials sector +5% last week provides broad sector support.
✅ Confirmations
5 analyst target raises reflecting rising-rate NIM expansion thesis
30Y yield >5.1% (highest in 1yr) — directly expands Schwab’s net interest margin
Financials sector +5% last week — broad sector tailwind confirmed
US 🇺🇸BreakoutScore 9252W High⚠ Earnings May 19☪ Halal
Palo Alto Networks continues its 52-week high breakout with platformization thesis intact. Jefferies Buy $265, Baird Outperform $220. Cybersecurity spend is non-discretionary as AI multiplies attack surfaces. ⚠ CRITICAL: Earnings Tuesday May 19 after-hours. Recommendation: enter HALF position Monday, add second half only on earnings confirmation (beat + raised guidance). If gap down >5%, honor the stop at $208.
✅ Confirmations
BUY signal active since Apr 20 at $167.78 — +36% follow-through, strongest cybersecurity trend
EU 🇩🇰PullbackScore 91GLP-1 LeaderPullback Entry☪ Halal
Novo Nordisk pulling back to $42.50–$45.50 support zone after a 15% correction from highs — offering an ideal entry into the secular GLP-1 growth story. Ozempic/Wegovy franchise generating 30%+ revenue growth with pipeline expanding into cardiovascular (SELECT trial) and NASH (phase 3). NVO is the global leader in obesity therapeutics with first-mover advantage and manufacturing scale. EU pharma provides defensive geographic diversification away from US tech concentration.
EU 🇪🇸BreakoutScore 91EU Bank BreakoutSabadell M&ACONV
BBVA breakout above $21 resistance as European bank sector surges on favorable rate environment. ECB holding rates while 30Y US yield >5.1% creates a positive NIM environment globally. Hostile bid for Banco Sabadell adds M&A premium — whether the deal closes or not, it signals BBVA’s consolidation ambitions. EU financials outperforming on credit spread tightening. Entry $21.20–$22.20 with stop below $19.80 prior support.
✅ Confirmations
EU bank sector breakout on favorable rate environment — ECB holding rates
Asia 🇨🇳MomentumScore 91China Trade DealDeep Value 8x PE☪ Halal
JD.com is a momentum play on the Trump-Xi trade deal follow-through entering week 2. As China’s largest direct e-commerce platform (vs Alibaba’s marketplace model), JD benefits directly from trade normalization via logistics and cross-border commerce. Trading at 8× forward PE — a massive valuation discount vs US e-commerce peers at 30–50×. KWEB ETF breakout last week on 302M volume confirms broad China internet sector rotation is underway.
✅ Confirmations
Trump-Xi trade deal week 2 — follow-through momentum from Boeing 200-jet order framework
8× forward PE — massive valuation discount vs US e-commerce (AMZN 50×, SHOP 40×)
KWEB ETF breakout on 302M volume confirms China internet sector rotation underway
Direct e-commerce model (own logistics) — higher margin than marketplace peers
IBB captures the healthcare sector rotation driven by GLP-1 tailwind (NVO, LLY) extending to broader biotech, plus an accelerating M&A wave (3 deals >$5B this quarter). Biotech provides defensive diversification from the tech-heavy portfolio while maintaining growth exposure via pipeline catalysts. Entry $140–$146 with stop below $133 prior support. Holdings include AMGN, GILD, VRTX, REGN — large-cap biotech with strong cash flow generation.
FDA regulatory headwinds — accelerated approval pathway tightening could delay pipeline
Drug pricing legislation (IRA Medicare negotiation expanding) compressing revenue expectations
Biotech small-cap washout if risk-off sentiment returns (high-beta sector in drawdowns)
Entry: $140–$146
Stop Loss: $133.00
TP1: $158.00
TP2: $170.00
R/R: 1:1.5
Horizon: 10 days
Synthesis — 10 Setup Summary
#
Ticker
Name
Region
Strategy
Score
Entry
Stop
TP1
R/R
1
AMAT
Applied Materials
US
Breakout
95
$418
$393
$480
1:1.6
2
CSCO
Cisco Systems
US
Momentum
93
$110
$105
$133
1:2.1
3
VRT
Vertiv Holdings
US
Momentum
93
$355
$336
$415
1:1.7
4
SCHW
Charles Schwab
US
Breakout
92
$88
$84
$99
1:1.5
5
PANW
Palo Alto Networks
US
Breakout
92
$228
$218
$280
1:2.4
6
NVO
Novo Nordisk
EU
Pullback
91
$42.5
$40.5
$51
1:2.0
7
BBVA
Banco Bilbao Vizcaya Argentaria
EU
Breakout
91
$21.2
$20
$24.5
1:1.6
8
JD
JD.com
Asia
Momentum
91
$30
$29
$37
1:2.6
9
XLK
Technology Select Sector SPDR
ETF
Momentum
90
$240
$228
$272
1:1.5
10
IBB
iShares Biotechnology ETF
ETF
Momentum
90
$140
$133
$158
1:1.5
Portfolio Parameters & Historical Performance
Performance data will be available after the sweep cycle completes.
How to use these levels
Entry zones are ranges — enter at the open (9:30–9:45 ET) if price falls within range. For EU setups, enter at the London open or early US session ADR price. Stop losses are hard exits, not mental stops. TP1 is the primary profit target: take 50% off at TP1, move stop to breakeven, trail the remainder to TP2. R/R ratios assume entry at the midpoint of the range. Horizon is the expected time to TP1 — if TP1 is not hit within 2× the horizon, reassess.
Methodology
1. Market Regime Detection
We compute a composite regime score from 6 components: VIX (sub-20 = 0 = bullish), SPX breadth (above 50/200 DMA), Credit (HYG spread normalization), DXY (weak dollar = bullish for multinationals), Liquidity (Fed balance sheet trend), and TLT (bond market signal). Score range 0–1: 0–0.30 = RISK-ON, 0.30–0.50 = NEUTRAL/Early Risk-Off, 0.50–0.70 = RISK-OFF, >0.70 = DEEP RISK-OFF. The VIX close behavior is the primary confirmation signal.
2. Multi-Strategy Screening
We run 3 complementary DSL screens: (a) Momentum Expansion: close>sma(close,20) && vol>sma(vol,20)*1.5 && rsi14>50 && rsi14<75, (b) Breakout Squeeze: close>sma(close,50) && atr(14)>atr(28)*1.2, (c) Pullback-to-Support: rsi14<45 && close>sma(close,200) && close<sma(close,50)*1.05. Screened universe: US mega-caps, EU/ADR large-caps, Asian ADRs, and sector ETFs. Short Squeeze is excluded from all screens per protocol established March 20, 2026.
3. Composite Scoring (4 Factors)
Each setup receives a score 0–100 based on: Technical (40%) — RSI position, MACD signal, SMA alignment, volume vs average; Momentum (30%) — 1-week, 1-month, 3-month price performance; Confluence (20%) — number of independent signals aligned (min 3 required for A+); Catalyst (10%) — identifiable near-term catalyst (earnings, sector rotation, macro event). Only setups scoring ≥85 qualify as A+.
4. Anti-Dilution & Quality Filter
All selected tickers are vetted for dilution risk: no S-3 shelf registrations, ATM programs, PIPE structures, or aggressive underwriter relationships. Short Squeeze permanently excluded. Open-position exclusions applied per current portfolio state.
5. Validation & Ranking
Final ranking prioritizes: (1) earnings catalyst recency/quality, (2) geopolitical/macro thematic alignment, (3) momentum quality, (4) diversification requirements (min 5 US, 2 EU, 1 Asia, 2 ETF). R/R minimum of 1:1.5 enforced for all setups. Sharia compliance tagged on every setup.
Fundamental data: MCP QueryData (quote, social_sentiment, capital_flow, insider_transactions)
Generated: Monday, May 18, 2026
Disclaimer
This scanner is for informational and educational purposes only. It does not constitute financial advice, investment advice, or a recommendation to buy or sell any security.
All setups carry risk. Past performance of the DailyTickers scanner does not guarantee future results. Entry zones, stops, and targets are estimates based on technical analysis and are not guarantees of execution. Market conditions can change rapidly.
DailyTickers is not a registered investment advisor. All content is provided “as is” without warranty of any kind. Always consult a qualified financial advisor before making investment decisions.